From GenomeWeb Daily News: HHS Committee Opens Public Comment on Gene Patents
A National Institutes of Health task force has released a draft report on its findings about the effects of gene patenting on medicine, research, and business, and has issued a set of potential policy options for public consideration as part of the report.
The Secretary’s Advisory Committee on Genetics, Health, and Society, which meets this week to discuss a number of other genomics-related issues, will seek public comments until May 15, 2009, on the findings and policy options drafted by its task force.
The SACGHS task force worked with Duke University’s Center for Genome Ethics to draft policy options based on a variety of findings from case studies of certain tests, companies, illnesses, and research areas.
The participation of the smart folks at Duke is a good sign.
Biotech Ethics 
I hope they will consider my recent book on the topic: http://www.amazon.com/Who-Owns-You-Corporate-Philosophy/dp/1405187301/ref=sr_1_1?ie=UTF8&s=books&qid=1240240111&sr=1-1
drkoepsell:
Your comment (and link) would be a more valuable contribution to the discussion here if you told us why, or perhaps tell us the main argument of your book.
Thanks,
Chris.